| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| revolution medicine stock price | 1.24 | 0.9 | 6432 | 60 | 31 |
| revolution | 1.49 | 0.6 | 8143 | 39 | 10 |
| medicine | 1.85 | 0.3 | 8253 | 2 | 8 |
| stock | 1.95 | 0.7 | 8758 | 66 | 5 |
| price | 0.45 | 0.8 | 8536 | 100 | 5 |
The average of price targets set by Wall Street analysts indicates a potential upside of 31.9% in Revolution Medicines, Inc. (RVMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
What shares of common stock is being offered by Revolution Medicines?All of the shares of common stock are being offered by Revolution Medicines. In addition, Revolution Medicines has
When will Revolution Medicines report financial results for the second quarter?REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today announced that it will report financial results for the second quarter 2022 on Tuesday, August 9, 2022, after market close.
What is Revolution medicine?Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves customers worldwide.
